205 related articles for article (PubMed ID: 28576460)
1. The promising impact of molecular profiling on treatment strategies in oral cancers.
Foy JP; Saintigny P; Goudot P; Schouman T; Bertolus C
J Stomatol Oral Maxillofac Surg; 2017 Sep; 118(4):242-247. PubMed ID: 28576460
[TBL] [Abstract][Full Text] [Related]
2. Oral Cancer: Genetics and the Role of Precision Medicine.
Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
Dent Clin North Am; 2018 Jan; 62(1):29-46. PubMed ID: 29126492
[TBL] [Abstract][Full Text] [Related]
3. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
[TBL] [Abstract][Full Text] [Related]
4. Oral squamous cell carcinoma - progresses from risk assessment to treatment.
Mao L
Chin J Dent Res; 2012; 15(2):83-8. PubMed ID: 23509828
[TBL] [Abstract][Full Text] [Related]
5. A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence.
Reis PP; Waldron L; Perez-Ordonez B; Pintilie M; Galloni NN; Xuan Y; Cervigne NK; Warner GC; Makitie AA; Simpson C; Goldstein D; Brown D; Gilbert R; Gullane P; Irish J; Jurisica I; Kamel-Reid S
BMC Cancer; 2011 Oct; 11():437. PubMed ID: 21989116
[TBL] [Abstract][Full Text] [Related]
6. Oral premalignancy: new methods of detection and treatment.
Gillenwater A; Papadimitrakopoulou V; Richards-Kortum R
Curr Oncol Rep; 2006 Mar; 8(2):146-54. PubMed ID: 16507225
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Ghantous Y; Bahouth Z; Abu El-Naaj I
Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.
Ho MW; Field EA; Field JK; Risk JM; Rajlawat BP; Rogers SN; Steele JC; Triantafyllou A; Woolgar JA; Lowe D; Shaw RJ
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):594-9. PubMed ID: 23601832
[TBL] [Abstract][Full Text] [Related]
10. Oral Cancer: Genetics and the Role of Precision Medicine.
Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
Surg Oncol Clin N Am; 2020 Jan; 29(1):127-144. PubMed ID: 31757309
[TBL] [Abstract][Full Text] [Related]
11. The promise of stem cell markers in the diagnosis and therapy of epithelial dysplasia and oral squamous cell carcinoma.
Mohajertehran F; Sahebkar A; Zare R; Mohtasham N
J Cell Physiol; 2018 Nov; 233(11):8499-8507. PubMed ID: 29797575
[TBL] [Abstract][Full Text] [Related]
12. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
13. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
[TBL] [Abstract][Full Text] [Related]
14. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics.
Irimie AI; Braicu C; Cojocneanu-Petric R; Berindan-Neagoe I; Campian RS
Acta Odontol Scand; 2015 Apr; 73(3):161-8. PubMed ID: 25598447
[TBL] [Abstract][Full Text] [Related]
15. Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension.
Wang HM; Liao CT; Yen TC; Chen SJ; Lee LY; Hsieh CH; Lin CY; Ng SH
Oncotarget; 2016 Sep; 7(39):63082-63092. PubMed ID: 27590518
[TBL] [Abstract][Full Text] [Related]
16. Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics.
Malik UU; Zarina S; Pennington SR
Arch Oral Biol; 2016 Mar; 63():53-65. PubMed ID: 26691574
[TBL] [Abstract][Full Text] [Related]
17. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
18. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature.
Georgakopoulou EA; Troupis TG; Troupis G; Gorgoulis VG
J BUON; 2011; 16(4):613-6. PubMed ID: 22331711
[TBL] [Abstract][Full Text] [Related]
19. [Current concepts in diagnosis and treatment of oral malignant tumors].
Hullmann MM; Reichert TE
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Sep; 54(9):1083-8. PubMed ID: 21887623
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
